Although there may be many cytokines which affect the therapeutic effects of hDPSC transplantation on diabetic polyneuropathy, we confirmed that the effect of hDPSC transplantation on MNCV and SNCV in diabetic mice was negated by human VEGF- and human NGF-neutralizing antibodies. The gene discussed is NGF; the disease is diabetic polyneuropathy.